MoneyWorks4Me

Valiant Laboratories - Quaterly Results

08 Aug 2025 Evaluate
The Total revenue for the quarter ended June 2025 of  Rs. 510.07 millions grew by 170.11% from Rs. 188.84 millions.The Total Profit for the quarter ended June 2025 of Rs. 18.17 millions grew from Rs.-10.05 millions Operating profit Margin for the quarter ended June 2025 improved to 30.34% as compared to -2.14% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 510.07 188.84 170.11 510.07 188.84 170.11 1333.62 1820.52 -26.75
Other Income 6.71 21.74 -69.14 6.71 21.74 -69.14 54.28 96.82 -43.94
PBIDT 30.34 -2.14 -1517.76 30.34 -2.14 -1517.76 7.53 12.73 -40.85
Interest 0.73 0.53 37.74 0.73 0.53 37.74 1.75 0.78 124.36
PBDT 29.61 -2.67 -1208.99 29.61 -2.67 -1208.99 5.78 11.95 -51.63
Depreciation 5.14 5.04 1.98 5.14 5.04 1.98 20.25 19.48 3.95
PBT 24.47 -7.71 -417.38 24.47 -7.71 -417.38 -14.47 -7.53 92.16
TAX 6.30 2.34 169.23 6.30 2.34 169.23 7.02 -10.93 -164.23
Deferred Tax 0.46 1.46 -68.49 0.46 1.46 -68.49 6.46 -1.11 -681.98
PAT 18.17 -10.05 -280.80 18.17 -10.05 -280.80 -21.49 3.40 -732.06
Equity 434.50 434.50 0.00 434.50 434.50 0.00 434.50 434.50 0.00
PBIDTM(%) 5.95 -1.13 -624.90 5.95 -1.13 -624.90 0.56 0.70 -19.26
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..